NYSE:DAL
NYSE:DALAirlines

How Does Delta Stack Up After a 104.5% Five-Year Climb?

Trying to figure out what to do with Delta Air Lines stock right now? You are definitely not alone. The airline’s shares have caught the eye of investors, with Delta not just holding steady, but delivering impressive returns across most timeframes. Over the past week, Delta gained 2.2%, stacking on a 6.6% rise over the last 30 days. Zoom out further and you will spot an 80.7% gain in three years and a truly remarkable 104.5% climb in the past five. Clearly, this is a stock with no shortage of...
NYSE:LYV
NYSE:LYVEntertainment

Live Nation (LYV): Assessing Valuation Following Recent Share Price Performance

Live Nation Entertainment (LYV) has drawn some fresh attention from investors lately, with its stock movement over the past month sparking renewed curiosity about the company’s long-term performance and current valuation landscape. See our latest analysis for Live Nation Entertainment. Live Nation’s shares have cooled off a bit in recent weeks, but when you zoom out, the story looks a lot brighter. The stock has posted an impressive 18.29% share price return so far this year, and a stellar...
NasdaqGS:SRPT
NasdaqGS:SRPTBiotechs

Is Sarepta Therapeutics Set for a Comeback After 24% Jump on Gene Therapy Progress?

Let’s be honest: if you’re following Sarepta Therapeutics stock, it probably feels a bit like riding a rollercoaster. After falling sharply over the last year, with shares down about 82.6% in twelve months, Sarepta has recently shown signs of life. In just the past month, the stock is up 24.2%, and even the last week has brought in a small gain of 1.3%. That kind of whiplash makes it tough to know whether you’re catching a bargain or stepping into a value trap. What’s behind this big swing?...
NYSE:CRM
NYSE:CRMSoftware

Is There an Opportunity in Salesforce After AI Expansion Sparks Stock Bounce?

Thinking about what to do with Salesforce stock? You are not alone, and these days, there is more buzz and debate than ever. With a closing price of $254.83, Salesforce has seen its share price climb 4.8% in the past week and 4.7% over the last month, suggesting renewed interest or maybe just a touch of optimism in the cloud computing giant. Yet if you zoom out, the longer-term picture is less rosy: the stock is down 22.9% year-to-date and has slipped 11.7% over the past year. Still,...
NYSE:BUR
NYSE:BURDiversified Financial

Burford Capital (NYSE:BUR): Evaluating Valuation in Light of New YPF Litigation Timeline Update

Burford Capital (NYSE:BUR) recently disclosed a fresh update on its high-profile YPF litigation, with oral arguments for the main appeal now scheduled for late October 2025. This legal milestone could prove important for Burford’s ongoing operations and future outlook. See our latest analysis for Burford Capital. Burford Capital’s share price has taken investors on a rocky ride this year, falling nearly 20% since January as ongoing headline events, like the YPF legal saga and its upcoming...
NasdaqGS:IDCC
NasdaqGS:IDCCSoftware

A Fresh Look at InterDigital's (IDCC) Valuation Following New Licensing Deals in Wireless and EV Charging Tech

InterDigital (IDCC) has just renewed its patent license agreement with Sharp and signed a new licensing deal with an EV charger manufacturer. These developments reflect the company’s growing influence in wireless, video, and now EV charging technologies. See our latest analysis for InterDigital. The momentum behind InterDigital is hard to ignore, especially with recent licensing wins amplifying a strong run. Its year-to-date share price return sits at an impressive 93%, while the one-year...
NasdaqGS:VTYX
NasdaqGS:VTYXPharmaceuticals

Ventyx Biosciences (VTYX) Is Up 48.2% After Positive Phase 2 Data for Oral Cardiometabolic Therapy – Has The Bull Case Changed?

Ventyx Biosciences recently announced positive topline results from its Phase 2 clinical trial of VTX3232, showing significant reductions in key inflammatory biomarkers such as hsCRP and IL-6 in patients with obesity and cardiovascular risk factors. An interesting insight from the study is that VTX3232 achieved a robust safety and tolerability profile, both as a standalone therapy and in combination with semaglutide, highlighting its potential as a new oral anti-inflammatory option in...
NasdaqGS:CECO
NasdaqGS:CECOCommercial Services

Is Now the Right Time to Consider CECO Environmental After 66% Share Price Rally in 2025?

If you’ve been eyeing CECO Environmental and wondering whether it’s time to get in, stay patient, or take wins off the table, you’re not alone. This stock has been quietly (and not so quietly) rewarding attentive investors with some eye-popping returns. Just check out the numbers: up 6.7% over the past week, 5.9% in the last month, and an astonishing 66.1% so far this year. Zoom out further, and the gains are even more impressive: nearly 95% for the past year and a staggering 637% over the...
NYSE:JPM
NYSE:JPMBanks

JPMorgan Chase (JPM): Valuation Insights as Crypto Collateral and Strong Earnings Drive Investor Focus

JPMorgan Chase is making waves this week as it prepares to let institutional clients use Bitcoin and Ethereum as collateral for loans. This development underscores a new chapter for digital assets on Wall Street. This move, paired with solid gains in the bank’s investment banking and trading businesses, gives investors a lot to think about in terms of growth and market positioning. See our latest analysis for JPMorgan Chase. JPMorgan Chase’s latest moves come on the heels of strong financial...
NasdaqGS:MXL
NasdaqGS:MXLSemiconductor

MaxLinear (MXL) Is Down 8.0% After Reporting 56% Revenue Jump and Narrower Net Loss – Has the Bull Case Changed?

MaxLinear reported third quarter 2025 results, posting US$126.46 million in sales, a sharp increase from US$81.1 million a year earlier, and reducing its net loss to US$45.49 million from US$75.79 million in the same period. Management highlighted especially strong momentum in high-speed data center optical interconnects and signaled further growth prospects in 5G wireless and AI-driven infrastructure solutions. With MaxLinear’s revenue rising 56% year-over-year, we'll explore how this...
NasdaqGS:SIMO
NasdaqGS:SIMOSemiconductor

Evaluating Silicon Motion Technology (NasdaqGS:SIMO): Is the Current Share Price a Fair Reflection of Value?

Silicon Motion Technology (SIMO) stock has drawn attention recently, riding several months of strong performance. Investors are looking at what is driving these gains and how the company’s growth story stacks up from here. See our latest analysis for Silicon Motion Technology. Silicon Motion Technology’s share price has been on a tear this year, up more than 81% year-to-date, and that momentum has only accelerated recently with a 30% gain over the past three months. The company’s 1-year total...
NasdaqCM:NNE
NasdaqCM:NNEElectrical

Why NANO Nuclear Energy (NNE) Is Up After Breaking Ground on KRONOS MMR Prototype at Major University

NANO Nuclear Energy Inc. held a milestone ceremony at the University of Illinois Urbana-Champaign to mark the commencement of drilling and site preparation for its KRONOS MMR micro modular reactor prototype, signaling significant progress toward real-world demonstration and commercial deployment of its patented technology. This event underscores the company's leadership in developing resilient, advanced nuclear solutions to meet diverse power needs for data centers, industrial projects,...
NYSE:TNET
NYSE:TNETProfessional Services

TriNet (TNET): Assessing Valuation as New AI-Driven HR Tools Launch for SMBs

TriNet Group (TNET) introduced a new suite of AI-powered HR tools designed to help small and medium-sized businesses manage employees more efficiently. The latest features highlight TriNet’s ongoing focus on blending technology with human expertise. See our latest analysis for TriNet Group. Despite rolling out fresh AI offerings, TriNet Group’s share price return over the past year reflects ongoing challenges, with a 1-year total shareholder return of -20.02% and continued negative momentum...
NasdaqGS:PLXS
NasdaqGS:PLXSElectronic

Plexus (PLXS): Assessing Valuation After Upbeat Revenue Guidance and Q2 Earnings Beat

Plexus (PLXS) just delivered quarterly results that topped expectations for both revenue and profit, even as overall sales growth stayed mostly flat compared to last year. The company also issued upbeat revenue guidance, crediting wins with new customers and expanding market share for its positive outlook. See our latest analysis for Plexus. Plexus’s share price has powered up 15.4% over the past 90 days, a run that stands out against a mostly flat year-to-date performance. While momentum...
NYSE:KVUE
NYSE:KVUEPersonal Products

Kenvue (KVUE) Valuation in Focus After Tylenol-Autism Controversy and Activist Investor Pressure

Kenvue (NYSE:KVUE) stock has been on a wild ride recently, after public claims connecting Tylenol use during pregnancy to autism gained traction. The company has strongly challenged these allegations in formal responses to the FDA. See our latest analysis for Kenvue. After a bruising year marked by abrupt leadership changes, activist investor pressure, and headlines tying Tylenol to autism risk, Kenvue’s share price has retreated sharply. The stock is down 8.7% over the past month and has...
NYSE:MMI
NYSE:MMIReal Estate

Marcus & Millichap (MMI): Is the Recent Share Price Recovery Reflected in Its Current Valuation?

Marcus & Millichap (MMI) shares have seen some movement in recent weeks, prompting investors to examine the company’s overall trajectory. With real estate markets fluctuating, it is worth taking a closer look at how MMI is performing today. See our latest analysis for Marcus & Millichap. After a rocky start to the year, Marcus & Millichap’s share price has rebounded lately, with a 7.2% rise over the past week and a 5.2% gain in the last month. However, the past year’s total shareholder return...
NYSE:FLG
NYSE:FLGBanks

Does Flagstar Bank's (FLG) Credit Improvement Reveal a Turning Point in Its Long-Term Profit Strategy?

Flagstar Bank, National Association recently reported third-quarter 2025 results, highlighting improved credit quality with net charge-offs falling to US$73 million and a narrower net loss of US$36 million compared to a year ago. While year-on-year net interest income and sales declined, the quarter featured stronger revenue than expected and disciplined expense management alongside growth in commercial and industrial lending. Let's explore how Flagstar Bank's better-than-anticipated revenue...
NYSE:GAP
NYSE:GAPSpecialty Retail

Are Rising Costs at Gap (GAP) Masking Deeper Challenges in Capital Efficiency?

Recent reports have highlighted that Gap's same-store sales growth has remained stable but trails most competitors, while rising costs from store expansion have further reduced its free cash flow margin over the past year. A unique insight is that Gap's historical return on invested capital has been modest at 7.6%, suggesting less effective capital use compared to leading peers in the retail sector. We'll explore how concerns about Gap’s operational efficiency and rising costs may reshape...
NYSE:R
NYSE:RTransportation

Can Ryder’s (R) Stable Q3 Mask Deeper Shifts in Its Long-Term Strategic Direction?

Ryder System, Inc. recently reported third-quarter 2025 results with revenue of US$3.17 billion and net income of US$138 million, both essentially flat versus the prior year, alongside updated earnings guidance and the authorization of two new share repurchase programs. Despite stable revenue, the company's continued focus on asset-light supply chain and dedicated businesses contributed to its fourth straight quarter of earnings per share growth. We'll explore how Ryder's softer quarterly...
NasdaqGS:ONB
NasdaqGS:ONBBanks

Is There Now an Opportunity in Old National Bancorp After 6% Weekly Rally?

If you are weighing your next move with Old National Bancorp, you are certainly not alone. Investors are taking note as this regional bank’s stock has delivered a rollercoaster of returns lately. In just the past week, shares have climbed 6.0%, a sharp turnaround from last month’s dip of almost 5%. With a strong 15.4% return over the last year and an impressive 76.6% gain across five years, Old National has shown that its long-term story is anything but boring. What is driving these swings?...
NasdaqGS:IMCR
NasdaqGS:IMCRBiotechs

A Look at Immunocore (IMCR) Valuation Following Fresh Analyst Optimism on Positive Anzu-cel Trial Results

Immunocore Holdings (IMCR) is catching fresh investor attention after HC Wainwright reiterated its Buy rating, citing promising new clinical data from the Phase 1b trial for anzu-cel in metastatic uveal melanoma. This renewed analyst confidence also reflects optimism about Immunocore’s pipeline of oncology and immunotherapy treatments. See our latest analysis for Immunocore Holdings. Immunocore’s recent news has helped reignite momentum in its share price, with a 4.76% jump in the past day...
NYSE:NTST
NYSE:NTSTRetail REITs

Will Recent CEO Share Purchases Reshape Perceptions of NETSTREIT's (NTST) Management Alignment?

NETSTREIT is scheduled to report its third-quarter 2025 earnings after market close on Monday, October 27, and recent company filings reveal that CEO Mark Manheimer has increased his stake by purchasing 5,600 shares, raising his position by 1.80%. The CEO's personal investment, along with several analyst upgrades, has drawn increased investor interest ahead of the company’s earnings release. Following the CEO’s recent share purchase, we’ll explore how this development could shape NETSTREIT’s...
NYSE:POR
NYSE:PORElectric Utilities

A Closer Look at Portland General Electric’s Valuation After Dividend Reaffirmation and Upbeat Analyst Upgrades

On October 22, 2025, Portland General Electric (NYSE:POR) declared a quarterly dividend of $0.525 per share. This move reinforces its commitment to shareholder returns as the company navigates rising industrial demand and regulatory milestones. See our latest analysis for Portland General Electric. Portland General Electric’s share price has picked up momentum lately, gaining over 12% in the past 90 days as upbeat earnings, a steady dividend, and sector-wide bullishness around future energy...
NasdaqGS:GSHD
NasdaqGS:GSHDInsurance

Goosehead Insurance (GSHD): Revisiting Valuation After Q3 Growth, Digital Investment, and Share Buyback

Goosehead Insurance (GSHD) drew investor focus after reporting double-digit revenue growth and notable franchise expansion for the third quarter. The company also completed a share buyback and continued investments in its digital agent platform. See our latest analysis for Goosehead Insurance. Despite eye-catching revenue gains and fresh franchise openings, Goosehead Insurance’s share price is still feeling the after-effects of a tough year, with a year-to-date decline of nearly 30%. Recent...